NYSE Euronext welcomes DBV Technologies to its European market
Fourth French life sciences company to list in one month Paris, 29 March 2012 – DBV Technologies, creator of Viaskin ® , a new product used in the treatment of allergies, today celebrated its admission to trading on NYSE Euronext in Paris. …